Georgetown University
π¬πΉGuatemala
- Country
- π¬πΉGuatemala
- Ownership
- Private
- Established
- 1789-01-23
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.georgetown.edu
Effects of Reading to Preterm Infants on Baby and Parents' Well Being
Not Applicable
Completed
- Conditions
- Parental Infant BondingCardio-respiratory Stability in Preterm NICU Infants
- Interventions
- Other: Parental Reading Aloud
- First Posted Date
- 2015-08-10
- Last Posted Date
- 2020-01-28
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 18
- Registration Number
- NCT02518997
- Locations
- πΊπΈ
Medstar Georgetown University Hospital, Washington, District of Columbia, United States
A Multi-Institutional Registry for CyberKnife Stereotactic Accelerated Partial Breast Irradiation (CK-SAPBI)
- Conditions
- Breast Cancer
- First Posted Date
- 2015-05-29
- Last Posted Date
- 2019-07-17
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 200
- Registration Number
- NCT02457117
- Locations
- πΊπΈ
Georgetown University Hospital, Washington, District of Columbia, United States
A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer
- First Posted Date
- 2015-03-30
- Last Posted Date
- 2019-01-29
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 10
- Registration Number
- NCT02402036
- Locations
- πΊπΈ
Georgetown University, Washington, District of Columbia, United States
Exercise Intervention Metabolic Syndrome Prostate Cancer Black Men
Not Applicable
Completed
- Conditions
- Physical ActivityMetabolic SyndromeProstate Cancer
- Interventions
- Behavioral: Attention ControlBehavioral: Exercise
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 10
- Registration Number
- NCT02379559
- Locations
- πΊπΈ
Office of Minority Health and Health Disparities Research, Washington, District of Columbia, United States
A Cognitive Behavioral Therapy and Yoga Program for Trauma Symptoms
Not Applicable
Completed
- Conditions
- Stress Disorders, Post-Traumatic
- Interventions
- Behavioral: Cognitive Behavioral Therapy and Yoga
- First Posted Date
- 2015-02-23
- Last Posted Date
- 2022-06-07
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 45
- Registration Number
- NCT02368444
- Locations
- πΊπΈ
Yoga Studio, Albuquerque, New Mexico, United States
CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)
Phase 1
Terminated
- Conditions
- Invasive Ductal CarcinomaDCISBreast Cancer
- Interventions
- Radiation: CK Stereotactic Accelerated Partial Breast Irradiation
- First Posted Date
- 2015-02-19
- Last Posted Date
- 2018-04-13
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 2
- Registration Number
- NCT02365714
- Locations
- πΊπΈ
Georgetown University Hospital, Washington, District of Columbia, United States
Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
Phase 2
- Conditions
- Thymic CarcinomaThymus CancerThymus Neoplasms
- Interventions
- First Posted Date
- 2015-02-16
- Last Posted Date
- 2019-12-13
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 45
- Registration Number
- NCT02364076
- Locations
- πΊπΈ
Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States
Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach
Not Applicable
Terminated
- Conditions
- Esophageal CancerGastric Cancer
- Interventions
- Drug: Modified FOLFOX6Drug: Docetaxel/CapecitabineDrug: Cisplatin/IrinotecanDrug: Cisplatin/DocetaxelDrug: IRI/EPIDrug: EPI/DocetaxelDrug: Irinotecan/Docetaxel
- First Posted Date
- 2015-02-09
- Last Posted Date
- 2018-09-06
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 13
- Registration Number
- NCT02358863
- Locations
- πΊπΈ
Georgetown University, Washington, District of Columbia, United States
Phase I Study of Intravenous Artesunate for Solid Tumors
- First Posted Date
- 2015-02-02
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 19
- Registration Number
- NCT02353026
- Locations
- πΊπΈ
Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States
Nilotinib in Cognitively Impaired Parkinson Disease Patients 001
Phase 1
Completed
- Conditions
- Diffuse Lewy Body DiseaseParkinson's Disease DementiaParkinson's Disease
- Interventions
- First Posted Date
- 2014-11-02
- Last Posted Date
- 2015-12-16
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 12
- Registration Number
- NCT02281474
- Locations
- πΊπΈ
MedStar Georgetown University Hospital, Washington, District of Columbia, United States
Β© Copyright 2025. All Rights Reserved by MedPath